Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growthYong Zhao, Ai‐Ming Yu, Mei‐Juan Tu et al.|Biochemical Pharmacology|2015Cited by 64
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse modelsMei‐Juan Tu, Ai‐Ming Yu, Huichang Bi et al.|Cancer Letters|2018Cited by 50
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrestYong Zhao, Ai‐Ming Yu, Mei‐Juan Tu et al.|Scientific Reports|2016Cited by 43
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse modelsChao Jian, Ai‐Ming Yu, Mei‐Juan Tu et al.|Oncotarget|2017Cited by 29